Clinical and Genomic Landscape of FGFR3 Alterations Across Different Stages of Urothelial Cancer
Maximilian Haas(University of Freiburg), Markus Eckstein(Friedrich-Alexander-Universität Erlangen-Nürnberg), Bernd Wullich(Friedrich-Alexander-Universität Erlangen-Nürnberg), Roman Mayr(Ospedale di Bolzano), Johannes Breyer(University of Regensburg), Christian Bolenz(Heidelberg University), Ralph M. Wirtz(Siemens Healthcare (Germany)), Florian Roghmann(University Hospitals of the Ruhr-University of Bochum), Niklas Klümper(University of Bonn), Danijel Sikic(Friedrich-Alexander-Universität Erlangen-Nürnberg), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Arndt Hartmann, Veronika Bahlinger(Friedrich-Alexander-Universität Erlangen-Nürnberg), Maximilian Burger(University of Regensburg), Philipp Erben(Heidelberg University)
Cited by 7
Related Papers
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
|JNCI Journal of the National Cancer Institute|2010|716
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
|Leukemia|2012|417
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
|The American Journal of Surgical Pathology|2005|411
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|386